Parallax Volatility Advisers, L.P. Sesen Bio, Inc. Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.58 - $0.86 $41,957 - $62,212	72,340 New	72,340 $44,000
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $52,808 - $92,595	-72,340 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $292 - $512	-400 Reduced 0.55%	72,340 $59,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $56,009 - $357,153	72,740 New	72,740 $58,000
Q1 2019 May 15, 2019	SELL	$0.69 - $1.47 $31 - $66	-45 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.96 - $2.04 $17,364 - $36,899	-18,088 Reduced 99.75%	45 $0
Q2 2018 Aug 14, 2018	BUY	$1.04 - $3.29 $18,858 - $59,657	18,133 New	18,133 $35,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.